Company
Investors Transforming Medication Adherence Through AI
AICure is a leading AI-powered medication adherence and patient engagement platform for life sciences. By combining advanced computer vision, machine learning, and behavioral science, AICure delivers objective, real-time insights that improve patient outcomes, protect clinical trial integrity, and unlock greater value across the drug lifecycle.
Robust Patent Portfolio
AiCure has 84 Awarded Patents
30 Patents Pending around the world
8 Registered Trademarks
AICure Overview
AICure enables life sciences organizations to objectively measure and improve medication adherence, transforming one of healthcare’s most persistent challenges into actionable intelligence.
Our AI-native platform verifies dosing behavior in real-time, captures auditable patient behavioral data, and supports meaningful engagement at a global scale, without wearables or invasive hardware.
Backed by Strategic Vision
AICure is backed by Vive VC, a healthcare-focused investment firm dedicated to scaling transformative, category-defining technologies.
Vive VC’s backing provides AICure with strategic capital, operational expertise, and long-term partnership to accelerate product innovation, expand enterprise adoption, and deepen impact across clinical research, pharmaceutical commercialization, and patient care.
The Problem We Solve
• Over 50% of patients on long-term medications fail to adhere to prescribed regimens
• Medication non-adherence increases clinical trial duration, cost, and risk while compromising data integrity
• Poor adherence limits real-world treatment effectiveness and commercial performance
• Life sciences organizations lack objective, real-world visibility into patient behavior and engagement
The AICure Platform
AICure’s AI-native mobile adherence platform delivers clinician-defined medication reminders, verifies that the right patient takes the right medication at the right time using computer vision, and captures real-time, auditable adherence and behavioral data, without wearables or invasive hardware.
Value Across the Drug Lifecycle
AICure improves patient adherence and outcomes, reduces trial risk and cost, enables objective adherence verification, and generates differentiated Real-World Evidence supporting Health Economics and Outcomes Research.
Why AICure Now?
AICure sits at the intersection of AI, digital health, and patient engagement, addressing a multibillion-dollar global adherence challenge with validated technology, global scale, and strategic backing.
Leadership & Governance
AICure is led by a seasoned management team with deep expertise across artificial intelligence, healthcare, and life sciences. The leadership team brings decades of experience scaling enterprise technology platforms, executing within regulated environments, and partnering with global pharmaceutical and biotechnology organizations.
Following the acquisition by Vive VC, AICure benefits from enhanced governance, strategic oversight, and operational support. Our governance framework reflects best-in-class standards for data privacy, regulatory compliance, security, and ethical AI deployment, ensuring long-term durability, trust, and accountability for customers and partners worldwide.
Looking Ahead
AICure is building the intelligence layer that powers medication adherence and patient engagement across the entire drug lifecycle.
Growing Footprint in Clinical Trials
AiCure has supported trials across 15+ therapeutic areas:
CNS/Neurology/Neurodegeneration
Allergies/Immunology
Population Health
Women’s Health
Psychiatry
Respiratory
Oncology
Infectious Disease
Endocrinology
Cardiovascular
Dermatology
Gastrointestinal
Pediatrics
Ophthalmology
Pain